TXG
10X Genomics$36.25
TXG info1.43%ย โ€ข 24 H
Dividend Yield:-
Global Rank#3448
Market Cap$4.25B
YTD Performance-33.80%
P/E-16.63
Revenue$618.73M
Change 7d0.19%
SP500 BenchmarkUnderperform
P/S6.86
Earnings-$255.10M

10X Genomics (TXG) Stock Overview

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

TXG Stock Information

SymbolTXG
Address
6230 Stoneridge Mall RoadPleasanton, CA 94588-3260United States
Founded-
Trading hours9:30 AM - 4:00 PM ET
Websitehttps://www.10xgenomics.com
Country๐Ÿ‡บ๐Ÿ‡ธ United States
Phone Number925 401 7300

10X Genomics (TXG) Price Chart

-
Value:-

10X Genomics Overview: Key Details and Summary

Stock data
2023
Change
Price
$36.25
N/A
Market Cap
$4.25B
N/A
Shares Outstanding
117.17M
2.90%
Employees
1.24K
N/A
Shareholder Equity
805.74M
-1.45%
Valuation
2023
Change
P/E Ratio
-16.63
N/A
P/S Ratio
6.86
N/A
P/B Ratio
5.27
N/A
Growth
2023
Change
Return on Equity
-0.3166
N/A
Earnings
2023
Change
Revenue
$618.73M
N/A
Earnings
-$255.10M
N/A
EPS
-2.18
N/A
Earnings Yield
-0.0601
N/A
Gross Margin
0.6615
N/A
Operating Margin
-0.4288
N/A
Net income margin
-0.4123
N/A
Financial Strength
2023
Change
Total Assets
$1.03B
N/A
Total Debt
$95.18M
N/A
Cash on Hand
$429.98M
N/A
Debt to Equity
0.2771
12.55%
Cash to Debt
$4.52
-36.95%
Current Ratio
$4.85
-28.42%
ยฉ 2024 TopStocks.org
Facebook Icon
Twitter Icon
Linkedin Icon